Pancreatic Cancer Research

ResearcherUniversity of MiamiActive in the last 2 years

Samara P. Singh

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-5911-1499; OpenAlex author ID A5067118030. Sources: OpenAlex.

Their work

Papers
8 (first author 2, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
22
Papers, trials and grants by year

2021: 1 paper · 2022: 3 papers · 2023: 2 papers · 2024: 1 paper · 2025: 1 paper

Papers 8

  1. CREB Drives Acinar to Ductal Cells Reprogramming and Promotes Pancreatic Cancer Progression in Preclinical Models of Alcoholic Pancreatitis. Co-author DOI 10.1016/j.jcmgh.2025.101606↗
  2. Tumor Cell-Intrinsic p38 MAPK Signaling Promotes IL1α-Mediated Stromal Inflammation and Therapeutic Resistance in Pancreatic Cancer. Co-author DOI 10.1158/0008-5472.can-23-1200↗
  3. Cell-Autonomous Cxcl1 Sustains Tolerogenic Circuitries and Stromal Inflammation via Neutrophil-Derived TNF in Pancreatic Cancer. Co-author DOI 10.1158/2159-8290.cd-22-1046↗
  4. Remodeling of Stromal Immune Microenvironment by Urolithin A Improves Survival with Immune Checkpoint Blockade in Pancreatic Cancer. Co-author DOI 10.1158/2767-9764.crc-22-0329↗
  5. Distinct mechanisms of innate and adaptive immune regulation underlie poor oncologic outcomes associated with KRAS-TP53 co-alteration in pancreatic cancer. Co-author DOI 10.1038/s41388-022-02368-w↗
  6. Combined MEK and STAT3 Inhibition Uncovers Stromal Plasticity by Enriching for Cancer-Associated Fibroblasts With Mesenchymal Stem Cell-Like Features to Overco… Co-author DOI 10.1053/j.gastro.2022.07.076↗
  7. Emerging Role of CREB in Epithelial to Mesenchymal Plasticity of Pancreatic Cancer. First author DOI 10.3389/fonc.2022.925687↗
  8. Targeting Tumor-Stromal IL6/STAT3 Signaling through IL1 Receptor Inhibition in Pancreatic Cancer. First author DOI 10.1158/1535-7163.mct-21-0083↗

Closest collaborators

The 22 strongest of 22 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Siddharth Mehra · 8 shared papers, 2021–2025 · strength 1.28
  2. Nagaraj S. Nagathihalli · 8 shared papers, 2021–2025 · strength 1.28
  3. Austin R. Dosch · 7 shared papers, 2021–2025 · strength 1.02
  4. Iago De Castro Silva · 7 shared papers, 2021–2025 · strength 1.02
  5. Nipun B. Merchant · 7 shared papers, 2021–2025 · strength 1.02
  6. Jashodeep Datta · 5 shared papers, 2022–2024 · strength 0.71
  7. Anna Bianchi · 3 shared papers, 2023–2025 · strength 0.50
  8. Haleh Amirian · 3 shared papers, 2023–2025 · strength 0.50
  9. Supriya Srinivasan · 3 shared papers, 2021–2025 · strength 0.47
  10. Jashodeep Datta · 2 shared papers, 2021–2025 · strength 0.31
  11. Peter J. Hosein · 2 shared papers, 2022 · strength 0.24
  12. Christine Isabelle Rafie · 2 shared papers, 2022–2023 · strength 0.24
  13. Nilesh Deshpande · 2 shared papers, 2022–2023 · strength 0.24
  14. Tulasigeri M. Totiger · 1 shared paper, 2025 · strength 0.20
  15. Michael Nathan VanSaun · 1 shared paper, 2025 · strength 0.20
  16. Eli Gilboa · 1 shared paper, 2023 · strength 0.16
  17. William L. Hwang · 1 shared paper, 2023 · strength 0.12
  18. Ifeanyichukwu Chinedu Ogobuiro · 1 shared paper, 2023 · strength 0.12
  19. Carina Shiau · 1 shared paper, 2023 · strength 0.12
  20. Ben Z. Stanger · 1 shared paper, 2023 · strength 0.12
  21. Prateek Sharma MD · 1 shared paper, 2022 · strength 0.12
  22. Sulagna Banerjee · 1 shared paper, 2021 · strength 0.11

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.